Metabolon, Inc. · 1 hour ago
Data Analyst
Metabolon, Inc. is seeking an experienced professional with a strong background in data analysis, including expertise in mass spectrometry and chromatography. The ideal candidate will leverage their analytical skills to conduct thorough data analysis and quality control, delivering accurate insights and solutions to support the team's success and growth.
BiotechnologyHealth CareHealth DiagnosticsLife ScienceSoftware
Responsibilities
Analyze Liquid Chromatography - Mass Spectrometry (LC-MS) and LC-MSMS data to assess the presence, absence, and potential interferences of over 5,000 metabolites
Cultivate an in-depth understanding of mass spectrometry data to generate innovative ideas and automation solutions
Troubleshoot and resolve data acquisition issues from LC-MS instruments that may affect downstream data quality
Verify and adjust chromatographic peak integrations to ensure accuracy
Participate in development opportunities, including:
Expanding Metabolon's chemical library by adding new chemical entries
Assisting in the creation and optimization of automated data curation systems
Integrating peak data for targeted analysis projects
Curating experimental data to support company R&D initiatives
Qualification
Required
Bachelor's degree in physical sciences, mathematical sciences, or a related STEM field
2+ years of experience in analyzing data (strongly preferred)
Strong analytical skills and attention to detail
Proven ability to learn and adapt to new software tools
Motivated and goal-oriented, with a passion for continuous improvement
Company
Metabolon, Inc.
Almost every factor that affects health – from genetics and the microbiome to disease and lifestyle – exerts its influence by altering metabolite levels in the body or other biological system.
Funding
Current Stage
Late StageTotal Funding
$267.2MKey Investors
National Institutes of HealthTrinity CapitalEssex Woodlands Healthcare Partners
2025-01-06Series Unknown· $7.5M
2024-06-25Grant
2024-05-16Debt Financing· $60M
Recent News
2025-11-04
2025-09-10
Company data provided by crunchbase